U.S. Specialty Stores Stock News

Wondering if Visteon at around US$98.65 is offering real value or just recent excitement? This article walks through what the current share price might be implying about the business. The stock has shown sharp moves recently, with returns of 4.9% over 7 days, 16.8% over 30 days, 1.8% year to date and 38.6% over 1 year, set against weaker 3 year and 5 year returns of 32.3% and 15.6% declines. These mixed time frames suggest sentiment around Visteon has shifted at different points, which can...

Bausch + Lomb recently secured FDA 510(k) clearance for its Bi-Blade+ vitrectomy cutter and Adaptive Fluidics upgrade while launching the enVista Envy intraocular lens in Europe and showcasing an expanded portfolio at the ASCRS 2026 meeting. Together, these advances deepen the company’s presence in premium surgical vision care by emphasizing intraocular pressure stability, surgical efficiency and full-range vision options. We’ll now explore how the Bi-Blade+ and Adaptive Fluidics clearance...

State Street Q1 2026 earnings at a glance State Street (STT) has opened 2026 with a steady earnings profile, coming off Q4 2025 revenue of US$3.7b and basic EPS of US$2.46, backed by trailing twelve month revenue of US$13.9b and EPS of US$9.55. The company has seen revenue move from US$12.9b in the twelve months to Q4 2024 to US$13.9b in the latest twelve month period, while EPS over the same windows shifted from US$8.34 to US$9.55. This gives a clear sense of how the income statement is...

Earlier this month, Science Applications International Corp. announced its role as NASA’s mission assurance partner for the completed Artemis II lunar mission, providing safety analysis, risk mitigation tools, and real-time oversight across the Space Launch System, Orion spacecraft, ground systems, and crew survival over the nearly 10‑day journey. The company’s deep integration into Artemis II, from cross-program hazard analysis to post‑flight lessons learned, highlights its embedded...

Badger Meter (BMI) has opened 2026 earnings season with Q1 results that sit against a trailing 12 month backdrop of US$916.7 million in revenue, basic EPS of US$4.82 and net income of US$141.6 million. The most recent reported quarter in 2025 showed revenue of US$220.7 million, basic EPS of US$1.14 and net income of US$33.6 million. Over the past six reported quarters, revenue has moved from US$205.2 million in Q4 2024 to a range between US$222.2 million and US$238.1 million through 2025,...

Alcoa Q1 2026 Earnings Snapshot Alcoa (AA) opened 2026 with Q1 revenue of US$3.2 billion and basic EPS of US$1.61, setting the tone for how the year is starting to shape up against prior performance. Over recent quarters, revenue has moved between US$3.0 billion and US$3.5 billion while quarterly EPS has ranged from roughly US$0.63 to US$2.08, giving investors a clear view of how top line and EPS have tracked together through different pricing and production conditions. With margins backing...

Bank First (BFC) opened 2026 with Q1 total revenue of US$63.7 million and basic EPS of US$1.78, alongside trailing twelve month revenue of US$193.7 million and EPS of US$7.18 that reflect five year earnings growth of 13.4% per year and 7.1% growth in the most recent year. Over the last few reported periods, revenue has moved from US$41.1 million in Q4 2024 to US$42.7 million in Q1 2025 and US$44.9 million in Q4 2025 before reaching US$63.7 million in Q1 2026, while quarterly EPS has ranged...

Wondering if Veeva Systems at around US$167.95 is offering fair value or a potential bargain? This article breaks down what the current price might really imply. The stock has recently moved 10.9% over the past week, while returns over 30 days, year to date, 1 year and 5 years are negative. This may leave you questioning whether the recent move reflects changing expectations or just short term noise. Recent commentary around Veeva Systems has focused on its role within healthcare and life...

Cohen & Steers (CNS) has opened 2026 with Q1 revenue of US$145.6 million and basic EPS of US$0.82, supported by net income of US$42.4 million, setting a clear marker for how the year is starting to shape up. Over recent quarters the company has seen revenue move from US$134.5 million in Q1 2025 to US$143.8 million in Q4 2025 and now US$145.6 million in Q1 2026. Basic EPS has ranged from US$0.68 to US$0.90 across that period, giving investors a detailed view of how the top and bottom line are...

Toll Brothers, Inc. has recently expanded and refreshed its luxury portfolio, opening and announcing new communities and model homes across Arizona, Texas, Nevada, South Carolina, New York, and South Carolina, while winding down sales at select high-end enclaves in California and Texas. This cluster of openings, upcoming launches, and “final opportunity” sell-downs highlights how Toll Brothers is actively rotating inventory across affluent, supply-constrained markets while leaning on its...

Independent Bank (INDB) opened 2026 with Q1 results that keep the focus firmly on the income statement, with recent quarters showing revenue stepping up from US$155.8 million in Q3 2024 to US$249.2 million in Q4 2025 and basic EPS moving from US$1.01 to US$1.52 over the same span, supported by trailing twelve month net income of US$205.1 million. Over that period, trailing revenue has shifted from US$653.5 million to US$792.1 million and trailing EPS has moved from US$4.52 to US$4.44, giving...

Definium Therapeutics is scheduled to present at the 25th Annual Needham Virtual Healthcare Conference. The conference appearance is expected to highlight the company’s latest developments for investors and healthcare industry participants. The event brings additional attention to NasdaqGS:DFTX at a time when the stock last closed at $22.68. For investors watching NasdaqGS:DFTX, this conference slot puts a fresh spotlight on Definium Therapeutics at a time when the share price sits at...

WaFd (WAFD) has posted Q2 2026 results with total revenue of US$193.4 million and basic EPS of US$0.82, setting the tone for another earnings season where profitability is front and center. The bank has seen quarterly revenue move from US$177.0 million in Q2 2025 to US$185.3 million in Q4 2025 and then to US$193.4 million in Q2 2026, while basic EPS over the same period has gone from US$0.65 to US$0.73 and now US$0.82, giving investors a clear view of how earnings are tracking alongside the...

InvenTrust Properties (IVT) has agreed to issue US$250 million of senior unsecured notes through a private placement, a financing decision that reshapes its debt profile and provides investors with fresh information on liquidity and leverage. See our latest analysis for InvenTrust Properties. The new US$250 million note issuance lands at a time when momentum in InvenTrust Properties’ share price has been building, with a 90-day share price return of 12.21% and year-to-date share price return...

Insteel Industries Q2 2026 earnings snapshot Insteel Industries (IIIN) has put fresh numbers on the table for Q2 2026, reporting revenue of US$172.7 million and basic EPS of US$0.27 on net income of US$5.2 million, with the trailing twelve months showing EPS of US$2.18 on net income of US$42.5 million. Over the past six quarters, revenue has moved within a band from US$129.7 million in Q1 2025 to US$179.9 million in Q3 2025, while quarterly EPS has ranged from US$0.06 to US$0.78, providing a...

Owens Corning stock snapshot With no single headline event driving Owens Corning (OC) right now, the focus for investors is on how the recent share performance and fundamentals line up at around US$122.84 per share. See our latest analysis for Owens Corning. The recent 1 day share price return of 4.23% and 7 day return of 7.49% sit within a mixed picture, with a 30 day share price return of 13.89% contrasting with a 1 year total shareholder return decline of 8.65% but a 5 year total...

PrimeEnergy Resources (PNRG) has wrapped up FY 2025 with fourth quarter revenue of US$51.6 million and basic EPS of US$2.07, alongside trailing 12 month revenue of US$187.4 million and EPS of US$15.85. Over recent periods the company has seen quarterly revenue move from US$60.4 million in Q4 2024 to US$51.6 million in Q4 2025, while basic EPS shifted from US$1.33 to US$2.07 across the same quarters, with trailing net income at US$26.3 million. With net profit margin sitting at 14% over the...

If you are wondering whether Privia Health Group at around US$24 a share offers good value, or if you are paying up for future expectations, this article breaks down what the current price may be implying about the business. The stock has recently shown mixed momentum, with a 7.4% return over the past week and 11.3% over the last 30 days, while the 1 year return sits at 1.4% and the 3 year return shows an 8.4% decline. Recent attention on Privia Health Group has focused on its role in the US...

Why Masimo Is On Investors’ Radar Now With Masimo (MASI) recently closing at US$178.39, some investors are reassessing the stock after a strong year-to-date return and solid performance over the past 3 months, especially alongside positive annual revenue and net income growth. See our latest analysis for Masimo. The recent 25.6% 90 day share price return and 40.0% year to date share price return suggest momentum is building, even though the 5 year total shareholder return of a 27.6% decline...

Wondering if Match Group's current share price still offers value, or if most of the opportunity has already been priced in? This article focuses squarely on what you are getting for the price you pay. The stock recently closed at US$34.75, with returns of 7.0% over 7 days, 11.8% over 30 days, 9.5% year to date, 22.6% over 1 year, 4.0% over 3 years and a 74.9% decline over 5 years. Taken together, this gives a mixed picture for anyone thinking about timing an entry. Recent coverage has...

Dow (NYSE:DOW) has entered a definitive agreement to sell a minority stake in select U.S. Gulf Coast infrastructure assets to Macquarie Asset Management. The transaction is expected to generate up to $3b in cash proceeds and support annual cost reductions of $1b by 2026. The move is part of a broader effort to reshape Dow's cost structure and portfolio focus. For investors tracking NYSE:DOW, this deal comes as the stock trades around $39.92, with shares up 4.9% over the past week and 8.2%...

Earlier this year, Calumet reported quarterly results showing a 9.4% year-on-year increase in revenue but falling short of analysts’ revenue and EBITDA expectations. The combination of revenue growth and an earnings miss highlighted investors’ focus on Calumet’s longer-term transformation story rather than short-term forecast deviations. We’ll now examine how this mix of year-on-year revenue growth and weaker-than-expected EBITDA shapes Calumet’s broader investment narrative. The best AI...

Earlier this month, AutoNation reported record after-sales gross profit, stronger customer financial services performance, higher new and used unit volumes, and US$785 million of share repurchases that reduced its share count by 10%. While management emphasized these operating gains and capital returns, analysts also pointed to weather-related disruptions and difficult prior-year tariff comparisons as headwinds for the first quarter. With record after-sales profitability set against expected...

Why ANI Pharmaceuticals Is On Investors’ Radar Today ANI Pharmaceuticals (ANIP) is drawing attention after recent share price moves, with the stock up about 5% over the past month but showing a roughly 8% decline over the past 3 months. See our latest analysis for ANI Pharmaceuticals. Looking past the recent 5.1% 1 month share price return, ANI Pharmaceuticals’ share price has softened over the last quarter while the 1 year total shareholder return of 12.8% and 5 year total shareholder return...